$JNJ Headlines Dow

New Post Public Reply Private Reply Replies (0) Message Board

Sep 23, 2014 at 10:12 AM

$JNJ Headlines

Dow industrials take flight, rally to uncharted territory
10:31 a.m. Sept. 19, 2014
- Michael Ashbaugh

7 reasons to be bullish on Microsoft
6:00 a.m. Sept. 18, 2014
- Jeff Reeves

5 pretty amazing facts about Alibaba
9:54 a.m. Sept. 15, 2014
- Tim Mullaney

Here’s what history says about the stock market in September
5:39 a.m. Sept. 2, 2014
- Mark Hulbert

This one stock sector can withstand all the ‘bubble’ talk
6:00 a.m. Aug. 21, 2014
- Jeff Reeves

Timing this market is guaranteed to make you a loser
1:02 p.m. Aug. 8, 2014
- Mark Hulbert

You don’t have to be a mega-mind to get this trade right
7:54 a.m. Aug. 6, 2014
- Jim Lowell

Mega caps with mega recommendations
7:54 a.m. Aug. 6, 2014
- Mark Hulbert

These eight health-care stocks could rise up to 75%
1:48 p.m. Aug. 5, 2014
- Philip van Doorn

J&J to call for voluntary return of morcellators
5:30 p.m. July 30, 2014
- MarketWatch.com

Chipotle tops S&P 500, Herbalife ignores ‘death blow’
1:14 p.m. July 22, 2014
- MarketWatch

Johnson & Johnson sets $5 billion share buyback
5:20 p.m. July 21, 2014
- Jim Jelter

Two rules of thumb for dumping your financial adviser
2:36 p.m. July 18, 2014
- Mark Hulbert

Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap

3:04 p.m. July 15, 2014
- blogs.marketwatch.com

Johnson & Johnson shares dip on cautious outlook

10:55 a.m. July 15, 2014
- blogs.marketwatch.com

Plug Power rallies; Lorillard drops on Reynolds merger
10:40 a.m. July 15, 2014
- Angela Johnson

Newscast: NBA wants to double TV fees
9:59 a.m. July 15, 2014
- MarketWatch

Johnson & Johnson tops forecasts, boosts outlook
7:57 a.m. July 15, 2014
- MarketWatch.com

Johnson & Johnson shares up 0.4% in premarket trade
7:51 a.m. July 15, 2014
- Tomi Kilgore

Johnson & Johnson sees full-year 2014 adjusted EPS of $5.85 to $5.92
7:50 a.m. July 15, 2014
- William L. Watts

Spectrum to Buy P&G's European Pet Ops

46 min ago9:25 a.m. Sept. 23, 2014
- The Wall Street Journal Interactive Edition

Dividends Vs. Capital Appreciation: Wrong Question

10:14 p.m. Sept. 22, 2014
- Seeking Alpha

Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog

6:20 p.m. Sept. 22, 2014
- Zacks.com

Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog

5:45 p.m. Sept. 22, 2014
- Zacks.com

Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog

4:45 p.m. Sept. 22, 2014
- Zacks.com

3 Stocks Reiterated As A Buy: MA, NTAP, JNJ

4:44 p.m. Sept. 22, 2014
- TheStreet.com

Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog

3:59 p.m. Sept. 22, 2014
- Zacks.com

FDA authorizes Tekmira to provide TKM-Ebola

11:20 a.m. Sept. 22, 2014
- Seeking Alpha

"A Unique Period of Time," Revisited

9:48 a.m. Sept. 22, 2014
- GuruFocus.com

The 10-Point: Gerard Baker on Arming the Kurds, Crude by Rail, Deadly Medicine and More

7:07 a.m. Sept. 22, 2014
- The Wall Street Journal Interactive Edition

Gynecologists Resist FDA Over Popular Surgical Tool

11:59 p.m. Sept. 21, 2014
- The Wall Street Journal Interactive Edition

The Point Of No (Negative) Return

7:00 a.m. Sept. 21, 2014
- Seeking Alpha

Gilead's Zydelig Approved In EU; Imbruvica In Wings

11:17 a.m. Sept. 19, 2014
- Investors Business Daily

Stock Market News for September 19, 2014 - Market News

10:10 a.m. Sept. 19, 2014
- Zacks.com

Who Is Working on Ebola?

9:59 a.m. Sept. 19, 2014
- Barrons.com

Big Pharma Might Finally Be Over the Alzheimer’s Hump

5:32 a.m. Sept. 19, 2014
- InvestorPlace.com

Retired Investors Should Not Fear Recessions Or A Bad Market: Part 1

11:13 a.m. Sept. 18, 2014
- Seeking Alpha

Don't Own A Company If You Wouldn't Display It On Your Wall

11:11 p.m. Sept. 17, 2014
- Seeking Alpha

Actavis Is The Best Bet In The Drug Sector

9:35 a.m. Sept. 17, 2014
- Seeking Alpha

Why It's Time for Allergan Shareholders to Take Some Profits

1:09 p.m. Sept. 16, 2014
- TheStreet.com

Regulatory Approval, Presentation of Data, Appointment, Clinical Study Results, and Increase in Quarterly Dividend - Research Reports on Johnson & Johnson, Merck, Medtronic, Amgen and Covidien
9:05 a.m. Today9:05 a.m. Sept. 23, 2014
- PR Newswire - PRF

OxySure Systems Selected for USPTO / Smithsonian Innovation Expo
8:02 a.m. Today8:02 a.m. Sept. 23, 2014
- ACCESSWIRE

Twenty Employers to Attend Annual Life Science Hiring Event Next Week
9:00 a.m. Sept. 22, 2014
- PR Newswire - PRF

Mr. David Guerette Joins Matamec's Board of Directors
3:01 p.m. Sept. 19, 2014
- Marketwire

New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma
9:15 a.m. Sept. 15, 2014
- PR Newswire - PRF

Sirius Solutions names Jessica Harris Director of Supply Chain Practice - Dallas/Ft. Worth Office
10:52 a.m. Sept. 12, 2014
- PR Newswire - PRF

Facial Care Market - Asia-Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019
8:48 p.m. Sept. 10, 2014
- PR Newswire - PRF

Transvaginal Mesh Lawsuit Latest Update News: J&J's Ethicon Loses another Mesh Trial
5:00 a.m. Sept. 9, 2014
- PR Newswire - PRF

Global Hepatitis C Market 2014-2018
9:58 p.m. Sept. 8, 2014
- PR Newswire - PRF

Jury Decides for Wexler Wallace LLP Client Against J&J Subsidiary: $3.27 Million
5:25 p.m. Sept. 5, 2014
- PR Newswire - PRF

We Are Mesh Survivors Applauds Verdict against Johnson and Johnson on
Pelvic Mesh: Jury Delivers $3.27 Million Verdict for Plaintiff Jo Huskey
in Johnson & Johnson Federal Trial on Pelvic Mesh Devices in West
Virginia
4:29 p.m. Sept. 5, 2014
- BusinessWire - BZX

Second Federal Ethicon Transvaginal Mesh Lawsuit Trial a $3.25 Million Win for Plaintiff, Bernstein Liebhard LLP Reports
3:47 p.m. Sept. 5, 2014
- PR Newswire - PRF

Upcoming Presentations, Technical Update, Study Results, and Marketing Authorization Application - Research Reports on Novartis, InterMune, Johnson & Johnson, Amgen and Merck
9:00 a.m. Sept. 5, 2014
- PR Newswire - PRF

Biotech Advancements in Innovative Cancer Therapy Reveal Developing Systemic Treatment Options - Company Receives Recommendation from World Health Organization for Lead Drug Candidate
8:15 a.m. Sept. 4, 2014
- PR Newswire - PRF

Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
12:01 a.m. Sept. 4, 2014
- PR Newswire - PRF

Bavarian Nordic Accelerates Ebola Vaccine Development Programs in Collaboration with the U.S. National Institutes of Health
12:00 a.m. Sept. 4, 2014
- Thomson Reuters ONE

Ironwood Appoints Two New Senior Executives to Support Continued
Growth as a Leader in Gastroenterology
5:00 p.m. Sept. 2, 2014
- BusinessWire - BZX

Acquisitions, Appointment, and Vaccine Recommendations - Research Reports on InterMune, Amgen, Johnson & Johnson, Merck and Medtronic
9:30 a.m. Aug. 28, 2014
- PR Newswire - PRF

IBM Watson Ushers in a New Era of Data-Driven Discoveries
12:01 a.m. Aug. 28, 2014
- PR Newswire - PRF

USIBC Concludes Successful Pharmaceutical Mission to India; Looks
Forward to Continued Dialogue and Collaboration with the Government of
India
11:46 a.m. Aug. 27, 2014
- BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Saltwater Intrusion Spurs Key Concrete Strategy in Florida

Water and concrete—two things that don't necessarily blend well in the realm of construction, right? Well, not unless you've got a trick up your sleeve like the folks at Provident Place in Pompano Beach, Florida. Facing the ever-looming threat of saltwater invasion, this little slice of Florida town is giving us a masterclass in protecting structures underwater. Why...

FAA Greenlights Boeing’s 737-10: What’s at Stake?

Breaking New Ground: Boeing 737-10 Certified Well, the folks at Boeing must be popping champagne, because the U.S. Federal Aviation Administration (FAA) just handed them the golden ticket: certification for the brand spankin' new Boeing 737-10. This ain't your average paper-pushing approval. We're talking nearly 1,000 test flights and what seems like a mountain of safety...

Call to Action: Make Disease Cure the Top Election Issue

A Call for Congressional Accountability The American Center for Cures is banging the drum for change, and they're banging it loud. Founded by Lou Weisbach, this group has come out swinging, urging Americans to slap disease onto the ballot in the midterms. Why? Because dealing with Alzheimer's, diabetes, heart disease, and cancer every year rips a whopping $1.1 trillion...

AT&T Surges with Major Revenue Boost and Fiber Expansion

AT&T's stirring up the pot with a third-quarter blowout that even the cleverest of market watchers had to tip their hats to. Barely anyone had five years ago pegged the sleepy telecom to launch past some of the juggernauts in service revenue growth. But here we are, folks—the company clocking a solid $32.3 billion in revenue, trundling in at a thick 5.3% from the...

Hyliion Partnership Woes: Investors Eye Legal Options

Hyliion's Rocky Partnership Sparks Market Concern If you've got your cash tied up in Hyliion Holdings Corp. (NYSE: HYLN), you've probably got an eye twitch by now. Last June, a damning report from Pelican Way Research threw a wrench in Hyliion's plans with VFG Holdings, calling into question the whole commercial rationale of their newest partnership. Imagine staking $133...

qBraid OS Launching Quantum Computing to New Heights

Paving a New Era for Quantum Computing That quantum computing isn't just about flashy algorithms anymore. It's about weaving together some downright powerful hardware under a seamless system. Enter qBraid OS, the new kid on the block offering a sprawling interface to drape quantum processors, CPUs, and NVIDIA GPUs over one cohesive operating system. Folks in the thick of...

FFR Set to Unveil Strategy at Nasdaq Event in NYC

An Exciting Day for FFR on Wall Street Hold onto your hats, investors! FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is about to make a splash in the big leagues at its much-anticipated Nasdaq listing ceremony. Slated for October 26 at the iconic Nasdaq Tower in NYC, it's a day that could pivot the company’s future centerpiece strategy, jacking up anticipation like...

Minnesota Cremation Services Expands Reach Statewide

Compassionate Expansion Reflecting Community Needs You talk to just about any family facing the heart-wrenching task of making decisions for a loved one's final farewell, and the story ain't pretty. Pricey packages, pressure to upgrade, and a constant side-eye wondering if they're getting the real deal. For Minnesota Cremation Services, though, this expansion is about...

China Reaffirms Financial Opening-Up, Targets Global Investors

A New Stage in China's Financial Opening-Up China's making some serious waves in the financial seas this week, kicking off the Annual Conference of the Financial Street Forum 2026 in Beijing. The big guns from China's financial regulatory bodies are rolling out policies with one clear message: they’re serious about opening up. They're launching pilot initiatives like...

Dairy Blends Market Eyes USD 15.38B by 2035 Growth

The dairy blends market, set to barrel towards USD 15.38 billion by 2035 according to Credence Research, isn't just a numbers game. It's a tug-of-war between different fats, regions, and regulations. For those betting on future market movements, this shouldn't be a passing glance. Rising from USD 9.97 billion in 2025, these figures suggest consistent waves rather than...